Asset Details
Do you wish to reserve the book?
MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia
Do you wish to request the book?
MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia
2016
Overview
Meningioma-1 (MN1) overexpression is frequently observed in patients with acute myeloid leukemia (AML) and is predictive of poor prognosis. In murine models, forced expression of MN1 in hematopoietic progenitors induces an aggressive myeloid leukemia that is strictly dependent on a defined gene expression program in the cell of origin, which includes the homeobox genes Hoxa9 and Meis1 as key components. Here, we have shown that this program is controlled by two histone methyltransferases, MLL1 and DOT1L, as deletion of either Mll1 or Dot1l in MN1-expressing cells abrogated the cell of origin-derived gene expression program, including the expression of Hoxa cluster genes. In murine models, genetic inactivation of either Mll1 or Dot1l impaired MN1-mediated leukemogenesis. We determined that HOXA9 and MEIS1 are coexpressed with MN1 in a subset of clinical MN1hi leukemia, and human MN1hi/HOXA9hi leukemias were sensitive to pharmacologic inhibition of DOT1L. Together, these data point to DOT1L as a potential therapeutic target in MN1hi AML. In addition, our findings suggest that epigenetic modulation of the interplay between an oncogenic lesion and its cooperating developmental program has therapeutic potential in AML.
Publisher
American Society for Clinical Investigation
Subject
/ Female
/ Genomics
/ Histone-Lysine N-Methyltransferase - genetics
/ Histone-Lysine N-Methyltransferase - metabolism
/ Homeodomain Proteins - genetics
/ Homeodomain Proteins - metabolism
/ Humans
/ Leukemia
/ Leukemia, Myeloid, Acute - genetics
/ Leukemia, Myeloid, Acute - metabolism
/ Leukemia, Myeloid, Acute - pathology
/ Male
/ Methyltransferases - genetics
/ Methyltransferases - metabolism
/ Mice
/ Myeloid Ecotropic Viral Integration Site 1 Protein
/ Myeloid-Lymphoid Leukemia Protein - genetics
/ Myeloid-Lymphoid Leukemia Protein - metabolism
/ Neoplasm Proteins - genetics
/ Neoplasm Proteins - metabolism
/ Oncogene Proteins - genetics
/ Oncogene Proteins - metabolism
/ Software
